LISAvienna: February 2022 - Newsletter available online

Today we highlight news items from BOKU, breathe ilo, Cebina, Epistome Austria, Eveliqure, Herba Chemosan, hi.health, Hookipa Pharma, myReha, NovoArc, piur imaging, Pregenerate, Ribbon Biolabs, rotable, Scarletred, TAmiRNA, Valneva, VelaLabs, ViruSure and XUND.

In addition, we update you on funding opportunities and events.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.